An orally administrable drug formulation containing levodopa and carbidopa, and having a short release time, is disclosed. The formulation is useful in the treatment of Parkinson's disease.
A drug formulation administrable by mouth for the treatment of central dopamine deficiency condition, said formulation comprising100 to 250 parts by weight of levodopa,10 to 25 parts by weight of carbidopa,a polymer mixture in an amount of 10 to 200% based on said drugs, said polymer mixture
